SEC Comment Letter 0000000000-22-012894 to BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: Nov. 29, 2022 · CIK: 0000811240 · Accession: 0000000000-22-012894
AI Filing Summary & Sentiment
File numbers found in text: 333-268528
Letter
United States securities and exchange commission logo November 29, 2022 John Beaver President & Chief Executive Officer BIOLASE, Inc. 27042 Towne Centre Drive, Suite 270 Lake Forest, CA 92610 Re:BIOLASE, Inc. Registration Statement on Form S-1 Filed November 22, 2022 File No. 333-268528 Dear John Beaver: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Istvan Hajdu
Show Raw Text
United States securities and exchange commission logo
November 29, 2022
John Beaver
President & Chief Executive Officer
BIOLASE, Inc.
27042 Towne Centre Drive, Suite 270
Lake Forest, CA 92610
Re:BIOLASE, Inc.
Registration Statement on Form S-1
Filed November 22, 2022
File No. 333-268528
Dear John Beaver:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Istvan Hajdu